查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1861524

醫療資產管理市場：2025-2032年全球預測（醫療設備、資訊科技基礎設施、設施管理、製藥和實驗室設備分類）

Healthcare Asset Management Market by Medical Equipment, Information Technology Infrastructure, Facilities Management, Pharmaceuticals, Laboratory Instruments - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，醫療保健資產管理市場將成長至 276.1 億美元，複合年成長率為 6.84%。

關鍵市場統計數據
基準年 2024 162.5億美元
預計年份：2025年 173.8億美元
預測年份 2032 276.1億美元
複合年成長率 (%) 6.84%

醫療資產管理正經歷一場策略轉型，其驅動力來自多重壓力：科技加速普及、監管審查日益嚴格，以及如何最大化現有資本投資的價值。管理影像和實驗室設備、藥品、 IT基礎設施以及設施系統的大型機構面臨著雙重挑戰：既要維持臨床營運的連續性，又要整合新的數位化功能，以實現預測性維護、遠端監控和更有效率的利用率追蹤。

隨著醫院和綜合醫療網路將韌性置於優先地位，它們正將工作重點從被動維護轉向基於生命週期的資產管治。這種轉變體現在對資產標籤、集中式資料平台以及連接採購、臨床工程和財務團隊的成熟管治流程的投資。這些變革並非可有可無，而是管理風險、實現臨床品質指標、控制營運成本的必要條件。此外，戰略觀點已超越單一資產，涵蓋設備群、軟體生態系統和設施網路。這種整體觀點需要跨學科協作以及清晰的技術應用和人才培養藍圖。

數位化、不斷變化的法規、網路安全和勞動力動態正在匯聚，重新定義醫療保健資產管理的優先事項和營運模式。

醫療資產管理格局正在發生變革，這既帶來了機遇，也帶來了風險。數位化轉型是其中最顯著的因素。連網影像設備、具備分析功能的資產管理軟體以及雲端託管的IT基礎設施正在改變醫療機構監控資產健康狀況和分配資源的方式。這個數位化層面實現了遠距離診斷和預測性維護，但也擴大了網路安全威脅的攻擊面，因此臨床工程部門和IT安全部門之間加強風險管理協作的需求日益成長。

同時，監管和合規框架也在不斷發展，以反映對病人安全和資料隱私的關注。醫療設備互通性、軟體檢驗和供應鏈透明度的更嚴格標準要求醫療機構記錄關鍵資產的來源和生命週期事件。此外，勞動力結構的變化，例如熟練生物醫學工程師的短缺以及對第一線員工資料素養的新要求，也在重塑營運模式。為了因應這些變革，領導者必須優先考慮跨職能培訓，投資於可互操作系統，並實施嚴格的供應商管治措施，以確保技術進步能夠轉化為在運轉率、病患安全和財務管理方面可衡量的改進。

對2025年關稅如何重塑醫療資產類別的採購經濟、備品策略和供應商在地化決策全面評估

2025年即將實施的新關稅為醫療資產管理者帶來了更複雜的成本、供應鏈和策略採購挑戰。這些關稅影響成品醫療設備和中間組件，改變了診斷影像設備、伺服器、網路設備、實驗室設備和某些藥品原料的採購經濟效益。採購團隊現在必須權衡短期成本影響與供應商多元化、近岸外包和長期服務協議等策略優勢，這些措施可以保護企業免受關稅短期波動的影響。

除了採購之外，關稅還會對維護策略和備件庫存產生間接影響。設施管理和臨床工程部門正在調整庫存策略，以確保臨床設備的可用性，同時避免將過多資金投入可能過時的零件。同時，供應商也重新評估其分銷網路，重新談判服務水準協議，並實現部分生產流程的本地化。這些發展為醫療機構提供了重新談判總體擁有成本條款並尋求提高生命週期支持透明度的機會。最終，資產負責人必須將關稅情境納入其資本規劃和供應商選擇流程，以確保醫療服務的連續性，同時保持財務紀律和供應商課責。

醫療資產管理細分領域的清晰化：將設備類型、 IT基礎設施、設施系統、藥品和實驗室設備與業務優先順序保持一致。

了解細分市場對於制定有針對性的資產管理策略至關重要，因為每項資產都有不同的營運、維護和監管要求。以醫療設備為例，市場可分為診斷影像設備、病患監測系統及手術器材。診斷影像設備可細分為CT掃描儀和核磁共振造影系統，手術器械則分為一般手術器械和微創手術器械。每個子集都需要各自的維護通訊協定、校準週期和臨床使用規則。以資訊科技基礎設施為例，市場可分為硬體、服務和軟體。硬體可細分為網路設備和伺服器，軟體則分為分析軟體和資產管理軟體。這些區分為本地部署與雲端部署、修補程式更新頻率和整合優先順序等決策提供了重要資訊。

在設施管理領域，市場分析涵蓋建築自動化、清潔和安防系統。建築自動化進一步細分為暖通空調系統和照明控制系統，安防系統則細分為門禁系統和監控系統。這些類別驅動著能源管理措施，並影響病患流動和安全通訊協定。在製藥領域，市場分析涵蓋生物製藥、品牌藥和學名藥。生物製藥細分為單株抗體和重組蛋白，品牌藥細分為循環系統和腫瘤藥物。這種分類影響低溫運輸物流、存貨周轉政策和監管文件。基於實驗室設備的市場分析分為分析設備和生命科學設備。分析設備細分為層析法和光譜系統，而生命科學設備包括細胞分析系統和PCR系統。實驗室設備的細分決定了校準要求、耗材規劃和生物安全考慮。

認知到這些不同的細分市場，資產管理者可以優先考慮平衡臨床影響、生命週期成本和監管合規性的干涉措施，並促進籌資策略，使供應商的能力與特定資產類別的要求保持一致，從而提高服務可靠性並減少下游營運摩擦。

區域策略考量在資產管理中體現了全球市場供應鏈、管理體制和技術採用模式的多樣性。

區域環境影響資產策略，因為供應鏈、管理體制和臨床工作流程在不同地區差異顯著。在美洲，採購週期和報銷機制往往優先考慮快速採用先進的影像和監控技術，因此重點在於整合、正常運作和靈活的資金籌措。在歐洲、中東和非洲，監管協調、市場成熟度差異以及基礎設施差異正在推動對模組化解決方案和多層級服務模式的需求，這些方案和模式能夠適應從都市區三級醫療中心到農村醫療機構的各種需求。在亞太地區，數位化平台的快速普及、醫院容量的擴張以及本地製造能力的增強正在加速對互聯IT基礎設施和設施自動化的投資。

這些區域差異意味著一刀切的資產管理方法行不通。相反，各機構應採取區域差異化的籌資策略，充分考慮供應商的企業發展、監管時間表和技術人才的可用性。此外，資本負責人應納入區域風險評估，包括政治、貿易和物流因素，以確保應對挑戰的能力。最終，區域洞察應指導供應商選擇、備件策略和培訓計劃，確保本地支援與集中管理相結合，從而在各種不同的環境中提供一致的患者照護服務。

供應商的產品藍圖、服務模式和管治實務如何決定醫療保健資產組合的長期價值和可靠性

主要企業透過其產品藍圖、服務模式和夥伴關係方式塑造資產管理生態系統，進而影響醫療服務提供者的選擇。那些整合強大的遠距離診斷功能、提供標準化互通性框架並承諾透明的生命週期支援協議的供應商，對於那些尋求最大限度減少停機時間並獲取營運情報的醫療系統而言，是理想的策略合作夥伴。同樣重要的是，能夠將技術維護與分析能力相結合，從而實現預測性維護計劃的服務供應商，這有助於提高設備可用性並有效利用臨床資源。

除了產品和服務能力之外，供應商管治也至關重要。企業應根據備件物流、韌體和軟體更新頻率、網路安全措施以及認證現場服務工程師的可用性等標準來評估供應商。與供應商就數據共用協議和按績效付費合約開展合作，有助於獎勵雙方提高運轉率並降低整體維護成本。最後，那些致力於透過培訓、認證和遠端支援來賦能員工和進行知識轉移的公司，將更有能力支援複雜資產組合的長期營運韌性和技術應用。

整合管治、採購、技術和人才策略，以增強醫療保健資產的韌性和價值的實用有效的領導策略

行業領導者必須將洞察轉化為可執行的行動，以提升韌性並最佳化資產績效。首先，企業應採用生命週期管治模型，並利用統一的指標管理運轉率、使用率和合規性。此模型規範了資產標籤、文件和交接流程，即使在所有權變更和服務合約轉換的情況下，也能確保問責制和資料完整性。

第二，領導者應優先投資於可互通的資產管理軟體和分析平台，這些平台能夠提供統一的介面，方便查看設備運作狀況、維護計畫和備件預測。此類平台支援預測性維護計劃，並能減少被動維護的工作量。第三，籌資策略應轉向總擁有成本契約，此類合約應包含明確的性能保證、明確的備件供應以及與服務績效掛鉤的處罰或補償。第四，為解決技術人員短缺問題，各組織應投資加強遠端支援能力、實施交叉培訓，並與供應商建立策略夥伴關係，以提升現場服務水準。最後，資本規劃應納入地緣政治和關稅風險評估，並考慮供應商多元化和近岸外包方案，以確保服務連續性，同時維持財務紀律。

調查方法結合了現場訪談、技術文件和基於情境的供應鏈分析，旨在得出切實可行且檢驗的資產管理見解。

本研究整合了定性和定量資訊，以確保提供平衡且實用的見解。主要資訊來源包括對臨床工程師、採購人員、醫院營運主管和供應商服務經理的訪談，以收集有關維護實務、備件物流和供應商績效的實地觀點。二級資訊來源包括官方監管文件、醫療設備和IT系統技術標準、產業白皮書以及展示成功實施案例的研究。對主要和二級資訊來源進行交叉檢驗，確保結論既反映實際情況，又符合既定標準。

我們的分析方法著重於三角測量和情境分析，而非預測建模。我們的資產類別分析利用設備技術手冊、服務等級協定和實際服務日誌，識別常見故障模式、維護頻率以及軟體更新與設備運轉率之間的相關性。我們的區域和關稅影響評估依賴供應鏈映射和供應商佈局分析，以可視化潛在的營運應對措施，而無需依賴市場規模估算。我們的調查方法強調假設的透明度、數據來源的清晰記錄以及敏感性檢驗，以確保我們的建議在各種營運條件下都具有穩健性。

概述重點在於生命週期管治、互操作系統和供應鏈彈性，以確保醫療服務的連續性和營運績效。

總之，醫療資產管理正處於一個策略轉折點，技術創新、監管變革和供應鏈動態交織在一起，重新定義了營運重點。未來發展需要各機構從各自獨立的維護實踐轉向以生命週期為中心的管治，採用能夠實現預測性維護的互通性技術，並實施使供應商激勵機制與臨床可用性相一致的籌資策略。關稅相關的波動凸顯了獎勵供應策略和透明的供應商合約對於保障醫療服務連續性的重要性。

透過結合強力的管治、有針對性的技術投資和靈活的採購慣例，果斷的領導者可以確保可靠的臨床營運，並從現有資產中挖掘更大價值。持續改進依賴臨床工程、IT、採購和供應商合作夥伴之間的協作關係，並以一致的數據管理和人才培養為支撐。遵循本報告中提出的建議和框架，各機構可以更好地應對新興風險，並抓住機遇，從而改善患者預後並提高營運效率。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 引入人工智慧驅動的預測性維護，以減少關鍵醫療設備的停機時間
  • 實施基於區塊鏈的供應鏈追蹤系統，以驗證醫療設備的真實性並確保合規性
  • 將醫院工作流程管理平台與基於物聯網的即時位置資訊系統整合以提高效率
  • 實施集中式多站點資產管理系統，實現聯合資料存取與分析
  • 採用內建網路安全和資料隱私控制功能的雲端原生解決方案
  • 實施醫療設備的永續性生命週期管理策略，包括對環境負責的處置方法
  • 利用數位雙胞胎技術對醫療設備性能和維護進行虛擬模擬和最佳化

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 醫療醫療設備資產管理市場

  • 診斷影像設備
    • 電腦斷層掃描器
    • 磁振造影
  • 病患監測系統
  • 手術器械
    • 一般外科器械
    • 微創手術器械

9. 資訊科技基礎設施驅動的醫療保健資產管理市場

  • 硬體
    • 網路裝置
    • 伺服器
  • 服務
  • 軟體
    • 分析軟體
    • 資產管理軟體

第10章：按設施管理分類的醫療保健資產管理市場

  • 建築自動化
    • 暖通空調系統
    • 照明控制系統
  • 清潔工作
  • 安全系統
    • 門禁系統
    • 監控系統

第11章：按藥物分類的醫療資產管理市場

  • 生物製藥
    • 單株抗體
    • 重組蛋白
  • 品牌藥
    • 循環系統藥物
    • 抗癌藥物
  • 學名藥

第12章 醫療資產管理市場（依檢測設備分類）

  • 分析設備
    • 層析法系統
    • 光譜分析儀
  • 生命科學設備
    • 細胞分析儀
    • PCR系統

第13章：按地區分類的醫療保健資產管理市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：依集團分類的醫療保健資產管理市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國醫療保健資產管理市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • GE HealthCare Technologies Inc.
    • Koninklijke Philips NV
    • Siemens Healthineers AG
    • McKesson Corporation
    • Cardinal Health, Inc.
    • Baxter International Inc.
    • Abbott Laboratories
    • Oracle Corporation
    • Accruent, LLC
    • International Business Machines Corporation
Product Code: MRR-69324464D212

The Healthcare Asset Management Market is projected to grow by USD 27.61 billion at a CAGR of 6.84% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 16.25 billion
Estimated Year [2025] USD 17.38 billion
Forecast Year [2032] USD 27.61 billion
CAGR (%) 6.84%

Healthcare asset management is undergoing a strategic reorientation driven by simultaneous pressures: accelerating technology adoption, heightened regulatory scrutiny, and the imperative to extract greater value from existing capital investments. Organizations that manage portfolios spanning imaging devices, laboratory instruments, pharmaceuticals, IT infrastructure, and facility systems are confronted with the dual challenge of sustaining uninterrupted clinical operations while integrating new digital capabilities that promise predictive maintenance, remote monitoring, and improved utilization tracking.

As hospitals and integrated delivery networks prioritize resilience, they are reallocating attention from reactive maintenance to lifecycle-based asset governance. This shift manifests through investments in asset tagging, centralized data platforms, and mature governance processes that align procurement, clinical engineering, and finance teams. These changes are not optional; rather, they are essential to manage risk, meet clinical quality metrics, and control operational costs. Moreover, the strategic lens now extends beyond individual assets to encompass networks of devices, software ecosystems, and facilities - a holistic view that requires cross-disciplinary collaboration and a clear roadmap for technology adoption and workforce development.

How digitalization, regulatory evolution, cybersecurity and workforce dynamics are jointly redefining priorities and operating models in healthcare asset management

The landscape of healthcare asset management is shifting in ways that reconfigure both opportunity and risk. Digital transformation is the most visible force: internet-connected imaging equipment, analytics-enabled asset management software, and cloud-hosted IT infrastructure are changing how organizations monitor asset health and allocate resources. This digital layer enables remote diagnostics and predictive maintenance, yet it also increases the attack surface for cybersecurity threats, intensifying the need for coordinated risk management across clinical engineering and IT security functions.

Concurrently, regulatory and compliance frameworks are evolving to reflect patient safety concerns and data privacy imperatives. Stricter standards for device interoperability, software validation, and supply chain transparency compel providers to document provenance and lifecycle events for critical assets. At the same time, workforce dynamics - including shortages in skilled biomedical technicians and new expectations for data literacy among frontline staff - are reshaping operational models. These transformative shifts require leaders to prioritize cross-functional training, invest in interoperable systems, and adopt rigorous vendor governance practices to ensure that technological gains translate into measurable improvements in uptime, patient safety, and fiscal stewardship.

Comprehensive assessment of how 2025 tariff actions are reshaping procurement economics, spare parts strategies and supplier localization decisions across healthcare assets

The introduction of new tariff measures in 2025 has created a complex overlay of cost, supply chain, and strategic sourcing considerations for healthcare asset managers. Tariffs affect both finished medical goods and intermediate components, altering procurement economics for imaging equipment, servers, networking hardware, laboratory instruments, and certain pharmaceutical inputs. Procurement teams must now weigh the immediate cost implications against the strategic benefits of supplier diversification, nearshoring, and long-term service agreements that insulate organizations from episodic tariff volatility.

Beyond procurement, tariffs have second-order effects on maintenance strategies and spare parts inventories. Facilities and clinical engineering departments are adjusting stocking policies to maintain clinical availability while avoiding excessive capital tied up in parts that risk obsolescence. In parallel, vendors are responding by revising distribution footprints, renegotiating service-level commitments, and localizing certain manufacturing processes. These responses create opportunities for healthcare organizations to renegotiate total-cost-of-ownership terms and to demand greater transparency in lifecycle support. Ultimately, asset managers must incorporate tariff scenarios into capital planning and vendor selection processes, ensuring continuity of care while preserving fiscal discipline and supplier accountability.

Segment-level clarity for healthcare asset management that aligns device types, IT infrastructure, facility systems, pharmaceuticals and laboratory equipment with operational priorities

Understanding segmentation is essential for targeted asset management strategies because assets exhibit distinct operational, maintenance, and regulatory profiles. Based on Medical Equipment, the market is studied across Imaging Equipment, Patient Monitoring Systems, and Surgical Instruments, with Imaging Equipment further examined through Computed Tomography Scanners and Magnetic Resonance Imaging Machines, and Surgical Instruments differentiated into General Surgical Instruments and Minimally Invasive Instruments; each subset requires tailored maintenance protocols, calibration cycles, and clinical utilization rules. Based on Information Technology Infrastructure, the market is studied across Hardware, Services, and Software, with Hardware further divided into Networking Equipment and Servers, and Software segmented into Analytics Software and Asset Management Software; these distinctions inform decisions about on-premises versus cloud deployments, patching cadences, and integration priorities.

In Facilities Management, the market is studied across Building Automation, Housekeeping, and Security Systems, with Building Automation further studied across HVAC Systems and Lighting Control Systems, and Security Systems distinguished into Access Control Systems and Surveillance Systems; these categories drive energy management initiatives and influence patient flow and safety protocols. Based on Pharmaceuticals, the market is studied across Biopharmaceuticals, Branded Drugs, and Generic Drugs, with Biopharmaceuticals further analyzed as Monoclonal Antibodies and Recombinant Proteins, and Branded Drugs examined through Cardiovascular Drugs and Oncology Drugs; pharmaceutical segmentation affects cold chain logistics, inventory turnover policies, and regulatory documentation. Based on Laboratory Instruments, the market is studied across Analytical Instruments and Life Science Instruments, with Analytical Instruments subdivided into Chromatography Systems and Spectroscopy Instruments, and Life Science Instruments including Cell Analysis Instruments and PCR Systems; laboratory segmentation determines calibration requirements, consumables planning, and biosafety considerations.

Recognizing these discrete segments enables asset managers to prioritize interventions that balance clinical impact, lifecycle costs, and regulatory compliance. It also facilitates procurement strategies that align vendor capabilities with specific asset-class requirements, thereby improving service reliability and reducing downstream operational friction.

Regional strategic considerations for asset management that reflect supply chain diversity, regulatory regimes and technology adoption patterns across global markets

Regional context shapes asset strategies because supply chains, regulatory regimes, and clinician workflows vary significantly across geographies. In the Americas, procurement cycles and reimbursement structures often prioritize rapid deployment of advanced imaging and monitoring technologies, which drives a focus on integration, uptime guarantees, and flexible financing. In Europe, Middle East & Africa, regulatory harmonization, diverse market maturities, and infrastructure variability create demand for modular solutions and multi-tiered service models that can be adapted to both urban tertiary centers and rural facilities. In Asia-Pacific, rapid adoption of digital platforms, expanding hospital capacity, and localized manufacturing capacities are accelerating investments in interconnected IT infrastructure and facility automation.

These regional distinctions mean that a one-size-fits-all approach to asset management is ineffective. Instead, organizations should adopt regionally differentiated procurement playbooks that account for vendor footprints, regulatory timelines, and the availability of technical talent. Moreover, capital planners should incorporate regional risk assessments - including political, trade, and logistical considerations - to ensure resilience. Ultimately, regional insights should inform vendor selection, spare parts strategies, and training programs so that the right mix of local support and centralized governance delivers consistent patient outcomes across diverse settings.

How vendor product roadmaps, service models and governance practices determine long-term value and reliability in healthcare asset portfolios

Key companies shape the asset management ecosystem through product roadmaps, service models, and partnership approaches that influence provider choices. Vendors that integrate robust remote diagnostics, offer standardized interoperability frameworks, and commit to transparent lifecycle support agreements stand out as strategic partners for healthcare systems aiming to minimize downtime while capturing operational intelligence. Equally important are service providers that can couple technical maintenance with analytics capabilities, enabling predictive maintenance programs that translate into higher equipment availability and more efficient utilization of clinical capacity.

In addition to product and service capabilities, vendor governance matters. Organizations should evaluate suppliers on criteria such as spare parts logistics, firmware and software update cadences, cybersecurity practices, and the availability of accredited field service engineers. Collaboration with vendors on data-sharing agreements and performance-based contracts can align incentives toward improved uptime and reduced total cost of care. Finally, companies that demonstrate commitment to workforce enablement and knowledge transfer - through training, certification, and remote support - will be better positioned to support long-term operational resilience and technology adoption across complex asset portfolios.

Practical, high-impact actions for leaders to align governance, procurement, technology and workforce strategies to strengthen healthcare asset resilience and value

Industry leaders must translate insights into executable actions that strengthen resilience and optimize asset performance. First, organizations should adopt a lifecycle governance model that integrates procurement, clinical engineering, finance, and IT under unified metrics for uptime, utilization, and compliance. This governance model should standardize asset tagging, documentation, and handoff processes so that accountability and data integrity persist across ownership changes and service contracts.

Second, leaders should prioritize investments in interoperable asset management software and analytics platforms that provide a single pane of glass for device health, maintenance scheduling, and spare parts forecasting. Such platforms enable predictive programs and reduce reactive maintenance workloads. Third, procurement strategies should shift toward total-cost-of-ownership contracts that include clear performance guarantees, defined spare parts availability, and penalties or credits tied to service outcomes. Fourth, workforce strategies must address technician shortages by investing in remote support capabilities, cross-training, and strategic partnerships with vendors for field service augmentation. Finally, leaders should incorporate geopolitical and tariff risk assessments into capital planning, diversifying suppliers and evaluating nearshoring options to preserve continuity of care while maintaining fiscal discipline.

Methodological approach that integrates frontline interviews, technical documentation and scenario-based supply chain analysis to produce practical and verifiable asset management insights

This research synthesizes qualitative and quantitative inputs to ensure balanced, actionable findings. Primary inputs include interviews with clinical engineers, procurement leaders, hospital operations executives, and vendor service managers to capture frontline perspectives on maintenance practices, spare parts logistics, and vendor performance. Secondary inputs comprise public regulatory documents, technical standards for medical devices and IT systems, industry white papers, and case studies demonstrating deployment outcomes. Cross-validation between primary and secondary sources ensures that conclusions reflect both lived operational realities and established standards.

Analytical methods emphasize triangulation and scenario analysis rather than predictive modeling. Asset-class analyses draw on device technical manuals, service-level agreements, and real-world service logs to identify common failure modes, maintenance cadences, and the interplay between software updates and device availability. For regional and tariff impact assessments, supply chain mapping and supplier footprint analysis were conducted to illustrate likely operational responses without relying on market sizing estimates. The methodology favors transparent assumptions, clearly documented data sources, and sensitivity checks to ensure that recommendations remain robust under varying operational conditions.

Concluding synthesis emphasizing lifecycle governance, interoperable systems and supply chain resilience to secure continuity of care and operational performance

In conclusion, healthcare asset management is at a strategic inflection point where technology, regulatory change, and supply chain dynamics converge to redefine operational priorities. The path forward requires organizations to move from siloed maintenance practices to lifecycle-centered governance, to adopt interoperable technologies that enable predictive maintenance, and to implement procurement strategies that align vendor incentives with clinical availability. Tariff-related disruptions underscore the importance of diversified supply strategies and transparent vendor agreements that protect continuity of care.

Leaders who act decisively will secure reliable clinical operations and extract greater value from existing assets by combining robust governance, targeted technology investments, and adaptive procurement practices. Sustained improvements will depend on collaborative relationships across clinical engineering, IT, procurement, and supplier partners, supported by consistent data practices and workforce development. By following the recommendations and frameworks presented in this report, organizations can strengthen readiness for emerging risks and capitalize on opportunities to enhance patient outcomes and operational efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Implementation of AI-driven predictive maintenance for critical medical equipment to reduce downtime
  • 5.2. Adoption of blockchain-enabled supply chain tracking for enhanced medical device authentication and compliance
  • 5.3. Integration of IoT-based real-time location systems with hospital workflow management platforms for efficiency gains
  • 5.4. Deployment of centralized multi-site asset management systems with federated data access and analytics capabilities
  • 5.5. Adoption of cloud-native healthcare asset management solutions with embedded cybersecurity and data privacy controls
  • 5.6. Implementation of sustainability-driven lifecycle management strategies for medical equipment including green disposal methods
  • 5.7. Utilization of digital twin technology for virtual simulation and optimization of medical device performance and maintenance

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Healthcare Asset Management Market, by Medical Equipment

  • 8.1. Imaging Equipment
    • 8.1.1. Computed Tomography Scanners
    • 8.1.2. Magnetic Resonance Imaging Machines
  • 8.2. Patient Monitoring Systems
  • 8.3. Surgical Instruments
    • 8.3.1. General Surgical Instruments
    • 8.3.2. Minimally Invasive Instruments

9. Healthcare Asset Management Market, by Information Technology Infrastructure

  • 9.1. Hardware
    • 9.1.1. Networking Equipment
    • 9.1.2. Servers
  • 9.2. Services
  • 9.3. Software
    • 9.3.1. Analytics Software
    • 9.3.2. Asset Management Software

10. Healthcare Asset Management Market, by Facilities Management

  • 10.1. Building Automation
    • 10.1.1. HVAC Systems
    • 10.1.2. Lighting Control Systems
  • 10.2. Housekeeping
  • 10.3. Security Systems
    • 10.3.1. Access Control Systems
    • 10.3.2. Surveillance Systems

11. Healthcare Asset Management Market, by Pharmaceuticals

  • 11.1. Biopharmaceuticals
    • 11.1.1. Monoclonal Antibodies
    • 11.1.2. Recombinant Proteins
  • 11.2. Branded Drugs
    • 11.2.1. Cardiovascular Drugs
    • 11.2.2. Oncology Drugs
  • 11.3. Generic Drugs

12. Healthcare Asset Management Market, by Laboratory Instruments

  • 12.1. Analytical Instruments
    • 12.1.1. Chromatography Systems
    • 12.1.2. Spectroscopy Instruments
  • 12.2. Life Science Instruments
    • 12.2.1. Cell Analysis Instruments
    • 12.2.2. PCR Systems

13. Healthcare Asset Management Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Healthcare Asset Management Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Healthcare Asset Management Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. GE HealthCare Technologies Inc.
    • 16.3.2. Koninklijke Philips N.V.
    • 16.3.3. Siemens Healthineers AG
    • 16.3.4. McKesson Corporation
    • 16.3.5. Cardinal Health, Inc.
    • 16.3.6. Baxter International Inc.
    • 16.3.7. Abbott Laboratories
    • 16.3.8. Oracle Corporation
    • 16.3.9. Accruent, LLC
    • 16.3.10. International Business Machines Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. HEALTHCARE ASSET MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. HEALTHCARE ASSET MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. HEALTHCARE ASSET MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY NETWORKING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY NETWORKING EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY NETWORKING EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY NETWORKING EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY NETWORKING EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY NETWORKING EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICS SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICS SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICS SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICS SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICS SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ASSET MANAGEMENT SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ASSET MANAGEMENT SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ASSET MANAGEMENT SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ASSET MANAGEMENT SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ASSET MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ASSET MANAGEMENT SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HVAC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HVAC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HVAC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HVAC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HVAC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HVAC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIGHTING CONTROL SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIGHTING CONTROL SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIGHTING CONTROL SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIGHTING CONTROL SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIGHTING CONTROL SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIGHTING CONTROL SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HOUSEKEEPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HOUSEKEEPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HOUSEKEEPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HOUSEKEEPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HOUSEKEEPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HOUSEKEEPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ACCESS CONTROL SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ACCESS CONTROL SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ACCESS CONTROL SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ACCESS CONTROL SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ACCESS CONTROL SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ACCESS CONTROL SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURVEILLANCE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURVEILLANCE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURVEILLANCE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURVEILLANCE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURVEILLANCE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURVEILLANCE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ONCOLOGY DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ONCOLOGY DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ONCOLOGY DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ONCOLOGY DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ONCOLOGY DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ONCOLOGY DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERIC DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERIC DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERIC DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY GENERIC DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY CELL ANALYSIS INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PCR SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PCR SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PCR SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PCR SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BUILDING AUTOMATION, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SECURITY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BIOPHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY BRANDED DRUGS, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LABORATORY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY LIFE SCIENCE INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY MEDICAL EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY IMAGING EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY INFORMATION TECHNOLOGY INFRASTRUCTURE, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY HARDWARE, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA HEALTHCARE ASSET MANAGEMENT MARKET SIZE, BY FACILITIES MANAGEMENT,